nLIGHT (LASR) has reported a significant improvement in profitability following its strategic decision to exit the commodity industrial fiber laser market. The company is successfully pivoting toward high-margin Aerospace, Defense, and Additive Manufacturing sectors, driving shares toward recent highs.
Shares of agilon health (AGL) and nLIGHT (LASR) faced significant downward pressure on March 12, 2026, as investors reassessed valuation following recent earnings reports and insider activity. While agilon struggles with persistent medical cost trends, nLIGHT is navigating executive share sales and institutional exits.
nLIGHT and KBR reported significant growth in their defense and aerospace divisions for Q4 2025, driven by a surge in demand for directed energy weapons and mission-critical intelligence services. nLIGHT’s 60% jump in A&D revenue and KBR’s $19.1 billion mission tech backlog signal a decisive industry shift toward advanced, high-energy technology and specialized military support.